A rapid and sensitive method was developed and validated using a normal phase liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) for determination of propranolol enantiomers in pharmaceuticals. Sample preparation involved a single extraction step by the addition of methanol. Separation of propranolol enantiomers was achieved on a Chiralcel OD-H chiral column using a mobile phase consisting of n-hexane-ethanol-ammonia (70:30:0.4, v/v/v), and the flow rate was 0.40 mL/min for 20 min. The analyte was monitored by tandem mass spectrometry with electrospray positive ionization in multiple reaction monitoring (MRM) mode, using the transitions of m/z 260.2 --> 116.0. Propranolol enantiomers can be completely separated. The linear range was 2.5-1000 microg/L, and the limit of quantification (LOQ) was 2.5 microg/L. The values for within day and between day precisions and accuracies were well within the generally accepted criteria for analytical methods. The relative standard deviations (RSDs) were less than 2.64%, and the recoveries of the two enantiomers were 99.08%-102.58% and 100.21%-103.16%, respectively. The separation method is accurate, convenient, reliable, efficient, and can be subsequently used for quality control of propranolol enantiomers in pharmaceuticals.

Download full-text PDF

Source
http://dx.doi.org/10.3724/sp.j.1123.2011.00026DOI Listing

Publication Analysis

Top Keywords

propranolol enantiomers
16
tandem mass
12
separation propranolol
8
normal phase
8
liquid chromatography
8
chromatography coupled
8
coupled tandem
8
mass spectrometry
8
enantiomers pharmaceuticals
8
propranolol
5

Similar Publications

Hypothesis: Nanoscale characterisation of the self-associated species formed by amphiphilic pharmaceuticals in aqueous solution carries relevance across their entire journey from development through to manufacture - relevant, therefore, not only as regards formulation of the drug products as medicines, but also potentially relevant to their bioavailability, activity, and clinical side effects. Such knowledge and understanding, however, can only be fully secured by applying a range of experimental and theoretical methodologies.

Experiments: Herein, we apply a synergistic combination of solubility, surface tension, SANS, NMR and UV spectroscopic studies, together with MD simulation and QM calculations, to investigate the meso-structures of propranolol hydrochloride aggregates in bulk aqueous solutions, at concentrations spanning 2.

View Article and Find Full Text PDF

Innovative chiral capillary silica monoliths (CSMs) were developed based on DNA nanoflowers (DNFs). Baseline separation of enantiomers such as atenolol, tyrosine, histidine, and nefopam was achieved by using DNF-modified CSMs, and the obtained resolution value was higher than 1.78.

View Article and Find Full Text PDF

Distinct advantages of surface enhanced Raman scattering (SERS) in molecular detection can benefit the enantioselective discrimination of specific molecular configurations. However, many of the recent methods still lack versatility and require customized anchors to chemically interact with the studied analyte. In this work, we propose the utilization of helicoid-shaped chiral gold nanoparticles arranged in an ordered array on a gold grating surface for enantioselective SERS recognition.

View Article and Find Full Text PDF
Article Synopsis
  • Infantile hemangioma (IH) is the most common tumor in children, primarily treated with propranolol, which affects blood vessel formation through a specific mechanism involving a protein called SOX18.
  • Recent research identified the mevalonate pathway (MVP) as a target of propranolol, highlighting its role in the formation of hemangiomas and confirming this through studies on stem cells from hemangiomas.
  • The study suggests that statins, which also target the MVP, could be repurposed to treat IH, revealing a new regulatory axis (SOX18-MVP) that may influence other conditions related to abnormal blood vessel growth.
View Article and Find Full Text PDF

Background: Infantile hemangioma (IH) is a benign vascular tumor that undergoes an initial rapid growth phase followed by spontaneous involution. A fibrofatty residuum remains in many tumors and often necessitates resection. We recently discovered that R(+) propranolol, the non-β blocker enantiomer, inhibits blood vessel formation of IH patient-derived hemangioma stem cells (HemSC) xenografted in mice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!